Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination

Beth Israel Med. Ctr., ACTU, New York

NY Univ. HIV/AIDS CRS, New York

Univ. of Rochester ACTG CRS, Rochester

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

Alabama Therapeutics CRS, Birmingham

Vanderbilt Therapeutics CRS, Nashville

Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis

Methodist Hosp. of Indiana, Indianapolis

University of Minnesota, ACTU, Minneapolis

Northwestern University CRS, Chicago

University of Colorado Hospital CRS, Aurora

UCLA CARE Center CRS, Los Angeles

Harbor-UCLA Med. Ctr. CRS, Torrance

Ucsf Aids Crs, San Francisco

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

Unc Aids Crs, Chapel Hill

Univ. of Miami AIDS CRS, Miami

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Univ. of Texas Medical Branch, ACTU, Galveston

USC CRS, Los Angeles

Stanford CRS, Palo Alto

San Mateo County AIDS Program, San Mateo

Santa Clara Valley Med. Ctr., San Jose

Marin County Dept. of Health & Human Services, HIV/AIDS Program & Specialty Clinic, San Rafael

The Ponce de Leon Ctr. CRS, Atlanta

Puerto Rico-AIDS CRS, San Juan